[BIO Asia-Taiwan]細胞治療於疫情/後疫情時代之臨床應用國際論壇

[BIO Asia-Taiwan]細胞治療於疫情/後疫情時代之臨床應用國際論壇

自2019年底開始,由新型冠狀病毒感染所引發(COVID-19)疫情蔓延全球,各國積極研發應對政策。近年全球細胞療法發展加速,透過幹細胞的修復與免疫調節功能,治療COVID-19的臨床試驗也急速增加。本次線上座談會集結各國醫師與學者,分別來自印尼、日本、馬來西亞、新加坡、泰國、台灣等國,分享各國細胞治療近況,說明在疫情與後疫情時代中,細胞治療如何成為重症治療新希望。

活動介紹

BIO Asia–Taiwan 2021 Satellite Conference Agenda
Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era

 【細胞治療於疫情 / 後疫情時代之臨床應用】國際論壇 
 
Mesenchymal stem cells (MSC) treatment of COVID-19 has accelerated in Asia. These precious and first-hand clinical experiences are worth sharing, communicating and reviewing with medical colleagues via academic conferences to provide more people with a better medical treatment. It is an honor to invite well-known scholars from Indonesia, Japan, Malaysia, Singapore, Thailand, Taiwan to share actual clinical cases from their respective hospitals on July 21th. 

This webinar is divided into two main sections. The first section will discuss clinical case reports of more than 40 COVID-19 patients. The second section will discuss the wide application of MSC, including treatment for neonatal cerebral palsy, premature infants with bronchopulmonary dysplasia and acute respiratory distress syndrome, systemic lupus erythematosus, as well as in other areas involving regenerative medicine and immunomodulation.

Date / Time: 2021.07.21/15:40-17:40 Taipei time (UTC+8)
Venue: Online Event Platform
Organizer: Asian Federation of Biotechnology. / Bionet Corp. / Cordlife Group. / StemCell Institute.
Session Chairs: Dr. Tokiko Nagamura-Inouen / Dr. Chang-Yao Tsao
 
報名參加
 

活動議程

Agenda (tentative):
Agenda (tentative):
Duration Topic / Speaker
15:40:00
-
15:49:05
Opening Remarks
Chairperson:
Topic:Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era.
Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.

Section1  Moderator
Dr. Chang-Yao Tsao / MD, PhD, Professor.
Internal of Medicine, Director, Immune Cell Therapy Unit,Chung Shan Medical University, Taichung, Taiwan.
15:49:05
-
16:03:13
TopicHuman Umbilical Cord-Derived Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome.
Dr.Hon-Kan Yip/Professor Level Attending Physician.
Kaohsiung Chang Gung Memorial Hospital, Taiwan.
16:03:13
-
16:16:48
TopicMesenchymal stem cell therapy for severe COVID-19: Sharing experience from Thailand.
Dr. Sithakom Phusanti
Deputy Director and Chief of Information Officer (CIO)/ Physician (Hematologist, Internist)
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Thailand.
16:16:48
-
16:31:00
TopicApplications of mesenchymal stem cells in immune disorders and lung injury, including severe COVID-19 infection.
Dr. Kang-Hsi Wu/ MD, Vice superintendent.
Chung Shan Medical University Hospital, Taichung, Taiwan.
16:31:00
-
16:45:24
Umbilical cord mesenchymal stromal cell as critical COVID-19 adjuvant therapy.
Professor Ismail H Dilogo/ MD, PhD.
Stem Cell Medical Technology Integrated Service Unit, Cipto
Mangunkusumo Central Hospital, Faculty of Medicine University Indonesia, Jakarta, Indonesia.
16:45:24
-
16:54:11
Section1 Panel Discussion
Moderator: Dr. Chang-Yao Tsao
Panelists: Dr.Hon-Kan Yip/Dr. Sithakom Phusanti/Dr. Kang-Hsi Wu/Professor Ismail H Dilogo
16:54:11
-
16:54:31
Section2 Moderator
Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.
16:54:31
-
17:05:24
The promise of cell therapy for pediatric acute/chronic lung disease: clinical case sharing.
Dr. Pei-Chen Tsao/ Director of neonatal intensive care unit.
Taipei Veterans General Hospital, Taiwan.
17:05:24
-
17:13:09
Stem Cells Technology 4.0 in Anti-Ageing and Anti-COVID.
Professor Phan Toan-Thang / Founding Director and Chief Scientific Officer
Cell Research Corporation, Singapore.
17:13:09
-
17:29:09
The anti-inflammatory and Immunomodulatory actions of human umbilical cord derived mesenchymal stem cells: Clinical Perspectives.
Dr. Chin Sze-Piaw / Clinical and Research Advisor
CYTOPEUTICS & Honorary Fellow of the Centre for Stem Cell Research (CSCR), Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman (UTAR), Malaysia.
17:29:09
-
17:39:07
Section2 Panel Discussion/ Final Conclusions
Moderator: Dr. Tokiko Nagamura-Inoue
Panelists: Dr. Pei-Chen Tsao/Dr. Ivor Lim/Dr. Chin Sze-Piaw

Organizer: Chris Tsai-Chairman of BIONET Corp. /Dr. Wen-Chien Lee- President of Asian Federation of Biotechnology.
 

報名參加